Economic impact of Lyme disease

Emerging Infectious Diseases

Volumn 12, Issue 4, 2006, Pages 653-660

  Zhang, Xinzhi ^a   Meltzer, Martin I ^a   Peña, César A ^b,d   Hopkins, Annette B ^b   Wroth, Lane ^c   Fix, Alan D ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c Care First Easton Branch   (United States)

^d MARYLAND DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; COST OF ILLNESS; DISEASE CONTROL; DISEASE SEVERITY; FEMALE; HEALTH CARE COST; HEALTH ECONOMICS; HUMAN; LYME DISEASE; MALE; TICK BITE; UNITED STATES;

EID: 33645463610     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1204.050602     Document Type: Article

References (24)

1. Steere AC, Malawista SE, Snydman DR, Shope RE, Andiman WA, Ross MR, et al. Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum. 1977;20:7-17.
2. Bujak DI, Weinstein A, Dornbush RL. Clinical and neurocognitive features of the post Lyme syndrome. J Rheumatol. 1996;23:1392-7.
3. Shadick NA, Phillips CB, Logigian EL, Steere AC, Kaplan RF, Berardi VP, et al. The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study. Ann Intern Med. 1994;121:560-7.
4. Johnson BJ, Robbins KE, Bailey RE, Cao BL, Sviat SL, Craven RB, et al. Serodiagnosis of Lyme disease: accuracy of a two-step approach using a flagella-based ELISA and immunoblotting. J Infect Dis. 1996;174:346-53.
5. Dressler F, Whalen JA, Reinhardt BN, Steere AC. Western blotting in the serodiagnosis of Lyme disease. J Infect Dis. 1993;167:392-400.
6. Tugwell P, Dennis DT, Weinstein A, Wells G, Shea B, Nichol G, et al. Laboratory evaluation in the diagnosis of Lyme disease. Ann Intern Med. 1997;127:1109-23.
7. Steere AC, Levin RE, Molloy PJ, Kalish RA, Abraham JH III, Liu NY, et al. Treatment of Lyme arthritis. Arthritis Rheum. 1994;37:878-88.
8. Wormser GP, Nadelman RB, Dattwyler RJ, Dennis DT, Shapiro ED, Steere AC, et al. Practice guidelines for the treatment of Lyme disease. The Infectious Diseases Society of America. Clin Infect Dis. 2000;31(Suppl 1):S1-14.
9. Benenson AS. Control of communicable diseases manual. 16th ed. Washington: American Public Health Association; 1995.
10. Hayes EB, Maupin GO, Mount GA, Piesman J. Assessing the prevention effectiveness of local Lyme disease control. J Public Health Manag Pract. 1999;5:84-92.
11. Centers for Disease Control and Prevention. Recommendations for the use of Lyme disease vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 1999;48(RR-7):1-17, 21-5.
12. Malawista SE. Lyme disease. In: Goldman L, Bennett JC, editors. Cecil textbook of medicine. 21st ed. Philadelphia: W.B. Saunders Company; 2000. p. 1757-61.
13. Centers for Disease Control and Prevention. Lyme disease - United States, 2000. MMWR Morb Mortal Wkly Rep. 2002;51;29-31.
14. Centers for Disease Control and Prevention. Notice to readers: final 2002 reports of notifiable diseases. MMWR Morb Mortal Wkly Rep. 2003;52:741-50.
15. Maes E, Lecomte P, Ray N. A cost-of-illness study of Lyme disease in the United States. Clin Ther. 1998;20:993-1008.
16. Centers for Disease Control and Prevention. Case definitions for infectious conditions under public health surveillance. MMWR Morb Mortal Wkly Rep. 1997;46(RR-10):20-1.
17. US Department of Labor. Consumer price index. [cited 2004 June 16]. Available from http://www.bls.gov/cpi/home.htm
18. Haddix AC, Teutsch SM, Corso PS, editors. Prevention effectiveness: a guide to decision analysis and economic evaluation. 2nd ed. New York: Oxford University Press; 2003. p. 70-1.
19. Fix AD, Strickland GT, Grant J. Tick bites and Lyme disease in an endemic setting: problematic use of serologic testing and prophylactic antibiotic therapy. JAMA. 1998;279:206-10.
20. Strickland GT, Karp AC, Mathews A, Peña CA. Utilization and cost of serologic tests for Lyme disease in Maryland. J Infect Dis. 1997;176:819-21.
21. Meek JI, Roberts CL, Smith EV Jr, Cartter ML. Underreporting of Lyme disease by Connecticut physicians, 1992. J Public Health Manag Pract. 1996;2:61-5.
22. Barbour AG, Fish D. The biological and social phenomenon of Lyme disease. Science. 1993;260:1610-6.
23. Steer AC, Sikand VK, Schoen RT, Nowakowski J. Asymptomatic infection with Borrelia burgdorferi. Clin Infect Dis. 2003;37:528-32.
24. Steere AC, Coburn J, Glickstein L. The emergence of Lyme disease [review]. J Clin Invest. 2004;113:1093-101.